Publications by authors named "Simone Scholz"

Claim this Profile
[
[Current Therapies in Superficial Malignant Tumors].
Simone Luisa Scholz, Anja Eckstein, Dirk Dekowski, Joachim Esser, Henrike Westekemper

Laryngorhinootologie· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton radiotherapy in advanced malignant melanoma of the conjunctiva.
Simone L Scholz, Joel Hérault, Andreas Stang, Klaus G Griewank, Daniel Meller

Graefes Arch Clin Exp Ophthalmol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912).
Simone L Scholz, Rajmohan Murali, Henrike Westekemper, Dirk Schadendorf, Klaus G Griewank

Ophthalmology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current Therapies in Superficial Malignant Tumors].
Simone Luisa Scholz, Anja Eckstein, Dirk Dekowski, Joachim Esser, Henrike Westekemper

Klin Monbl Augenheilkd· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
Simone J Scholz, Raffaele Fronza, Cynthia C Bartholomä, Daniela Cesana, Eugenio Montini

Hum Gene Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1 and BAP1 mutations in blue nevus-like melanoma.
Klaus G Griewank, Hansgeorg Müller, Louise A Jackett, Michael Emberger, Inga Möller, Simone L Scholz

Mod Pathol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Simone L Scholz, Inga Möller, Henning Reis, Daniela Süßkind, Johannes A P van de Nes

Invest Ophthalmol Vis Sci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Inga Möller, Rajmohan Murali, Hansgeorg Müller, Thomas Wiesner, Louise A Jackett, Simone L Scholz

Mod Pathol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature.
Johannes van de Nes, Karsten Wrede, Adrian Ringelstein, Mathias Stiller, Susanne Horn, Simone L Scholz

J Invest Dermatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
Johannes van de Nes, Marco Gessi, Antje Sucker, Inga Möller, Mathias Stiller, Simone L Scholz

J Neurooncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.
Klaus G Griewank, Bastian Schilling, Simone L Scholz, Claudia H Metz, Elisabeth Livingstone

Eur J Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Rajmohan Murali, Raghu Chandramohan, Inga Möller, Simone L Scholz, Michael Berger

Oncotarget· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of SDHD promoter mutations in various types of melanoma.
Simone L Scholz, Susanne Horn, Rajmohan Murali, Inga Möller, Antje Sucker

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.
Simone L Scholz, Henning Thomasen, Henning Reis, Inga Möller, Raid Darawsha

Invest Ophthalmol Vis Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies.
Frank A Giordano, Jens-Uwe Appelt, Barbara Link, Sebastian Gerdes, Christina Lehrer, Simone Scholz

Mol Ther Methods Clin Dev· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.
Stefan Stein, Simone Scholz, Joachim Schwäble, Mohammed A Sadat, Ute Modlich

Hum Gene Ther Clin Dev· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity.
Claudia A Montiel-Equihua, Lin Zhang, Sean Knight, Heba Saadeh, Simone Scholz

Mol Ther· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing.
Anna Paruzynski, Anne Arens, Richard Gabriel, Cynthia C Bartholomae, Simone Scholz

Nat Protoc· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation.
Zlatka Kostova, Jennifer Mariano, Simone Scholz, Carolin Koenig, Allan M Weissman

J Cell Sci· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis